新型冠状病毒肺炎相关肝损伤
COVID-19-Associated Liver Injury.
作者信息
Gildea Daniel T, Woo Stephanie M, O'Connor Corinne E, Rangnekar Amol S
机构信息
Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
Department of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC, USA.
出版信息
Hepat Med. 2023 Feb 21;15:1-9. doi: 10.2147/HMER.S384108. eCollection 2023.
This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients.
本综述分析了与新型冠状病毒肺炎（COVID-19）感染相关的肝损伤数据。我们讨论了COVID-19及其治疗对肝脏的已知影响以及病理生理学，回顾了药物性肝损伤作为COVID-19相关肝损伤病因的潜在作用，并提及了包括COVID-19胆管病和自身免疫性肝炎在内的其他重大结局报告。最后，我们回顾了COVID-19感染对肝移植受者的影响。
Zotero 插件